Skip to contentB
Bioxytran, Inc
B
BIXTBioxytran, Inc Q2 2016 · 10-Q
Revenue$55.63K$55.63K−6.3% vs Q2 2015 Net Income-$163.00K-$163.00KN/M vs Q2 2015 EPS Diluted-$0.01-$0.01N/M vs Q2 2015 Gross Profit$36,801−17.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
Operating Cash Flowderived-$11,738N/M Margins · derivedGross margin66.2%−9.1 pt vs Q2 2015
Operating margin-257.7%+2964.6 pt vs Q2 2015
Net margin-293.0%+2932.6 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 22, 2016 · 53 d after period end